Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements Of Cash Flows

v3.25.3
Condensed Consolidated Statements Of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (13,496,822) $ (9,029,973)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,880,793 2,373,312
Share based compensation 72,175 (16,199)
Credit loss provision 40,046 105,593
Fair value remeasurement of earnout consideration   (800,000)
Fair value remeasurement of warrant liability 7,531,044 974,823
Fair value remeasurement of embedded derivative liability   468,329
Fair value remeasurement of contingent forward contract (899,080)  
Fair value remeasurement of contingent value rights (23,132) (478,809)
Loss on extinguishment of debt 343,471 35,657
Gain on sale of assets   822
Loss on lease termination   215,415
Interest and accretion expense 269,909 2,312,054
Changes in assets and liabilities:    
Trade accounts receivable (81,531) 697,454
Inventories (300,508) 893,281
Income taxes (18,532) (83,062)
Other assets, net (1,145,270) (809,709)
Accounts payable 395,280 570,844
Accrued compensation and benefits 802,213 (510,484)
Customer deposits 2,461,077 (270,905)
Other accrued liabilities 1,700,111 236,089
Accrued interest (677,582) (1,278,378)
Net cash used in operating activities (1,146,338) (4,393,846)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (17,787) (29,749)
Proceeds from the sale of property, plant and equipment   6,118
Net cash used in investing activities (17,787) (23,631)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from loans payable 64,744 1,604,000
Payments against loans payable (8,609,793) (1,161,654)
Payments against related party loans payable (1,155,967)  
Payments related to debt issuance costs (38,613) (24,150)
Payments related to equity issuance costs (2,128,038) (237,536)
Proceeds from the issuance of common stock and pre-funded warrants under registered direct offering 9,690,790 1,000,000
Proceeds from the issuance of common stock on the exercise of pre-funded warrants 11,078  
Proceeds from the issuance of Series A and Series B warrants 10,298,134  
Proceeds from the issuance of common stock under at-the-market offering 351,372  
Proceeds from the issuance of Series B preferred stock   15
Payments for the termination of Series A warrants (267,391)  
Proceeds from issuance of common stock, net of shares withheld   9,775
Cash in lieu payment on fractional shares under reverse stock split   (1,132)
Payment of contingent consideration related to acquisition (2,500,000)  
Purchase of common stock   (6,098)
Net cash provided by financing activities 5,716,316 1,183,220
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 4,552,191 (3,234,257)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 1,151,348 5,396,343
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 5,703,539 2,162,086
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Income taxes paid 64,062 83,100
Interest paid 1,270,163 1,216,577
NONCASH FINANCING AND INVESTING ACTIVITIES:    
Loss on extinguishment of debt   (35,657)
Issuance of common stock for the settlement of loss contingencies $ 880,756  
Deemed dividend on Convertible Preferred Stock and PIPE Warrants   11,587,121
Conversion of redeemable convertible preferred stock to common stock   $ 15,277,055